AstraZeneca Gains After FDA Staff Recommends Brilinta - BusinessWeek: "AstraZeneca Plc gained in London trading after U.S. regulatory staff said the blood-thinner Brilinta is approvable if the drugmaker undertakes a study on its effectiveness in Americans once it’s marketed.
- Sent using Google Toolbar"
1 comment:
Are these people just stupid or are they blind paid shills, Is the FDA not watching the news as it related to the hanky panky going on in foreign studies by astrazeneca. There is good and seedy reason why these studies and the data are not matching up with the studies done in the US.
http://www.fcpablog.com/blog/2010/7/27/medical-ghosting-and-the-fcpa.html
I have a hard time believing they are that much out of touch with what's going on and approving these drugs blindly.
Post a Comment